(Q80786696)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18305467%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

title

Effective and safe treatment with cyclosporine in nephrotic children: a prospective, randomized multicenter trial (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18305467%20AND%20SRC:MED&resulttype=core&format=json

multicenter clinical trial

3 January 2020

main subject

1 reference

1 reference

K Ishikura

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18305467%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

M Ikeda

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18305467%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

S Hattori

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18305467%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

N Yoshikawa

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18305467%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

S Sasaki

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18305467%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

K Iijima

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18305467%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

K Nakanishi

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18305467%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

N Yata

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18305467%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

M Honda

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18305467%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

language of work or name

English

0 references

publication date

27 February 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18305467%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18305467%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

volume

73

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18305467%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

page(s)

1167-1173

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18305467%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18305467%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/ki.2008.24

3 January 2020

exact match

0 references

cites work

Long-term outcome of primary nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.24

7 January 2021

Nephrotic syndrome in childhood.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.24

7 January 2021

Early identification of frequent relapsers among children with minimal change nephrotic syndrome. A report of the International Study of Kidney Disease in Children

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.24

7 January 2021

Immunosuppressive agents in childhood nephrotic syndrome: a meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.24

7 January 2021

Risk factors for cyclosporine-induced tubulointerstitial lesions in children with minimal change nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.24

7 January 2021

Two-year cyclosporin treatment in children with steroid-dependent nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.24

7 January 2021

Recovery from cyclosporine-associated arteriolopathy in childhood nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.24

7 January 2021

Long-term ciclosporin treatment in children with steroid-dependent nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.24

7 January 2021

Ciclosporin treatment in children with steroid-dependent nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.24

7 January 2021

Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.24

7 January 2021

Independent risk factors for chronic cyclosporine induced nephropathy in children with nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.24

7 January 2021

A pharmacokinetic study of Neoral in childhood steroid-dependent nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.24

7 January 2021

Long-term clinical and pathological effects of cyclosporin in children with nephrosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.24

7 January 2021

Follow-up study of children with nephrotic syndrome treated with a long-term moderate dose of cyclosporine.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.24

7 January 2021

Management of nephrotic syndrome in children

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.24

7 January 2021

Cyclosporin treatment of glomerular diseases

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.24

7 January 2021

The Management of Idiopathic Nephrotic Syndrome in Children

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.24

7 January 2021

Evidence-based management of steroid-sensitive nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.24

7 January 2021

Cyclosporine therapy monitored with abbreviated area under curve in nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.24

7 January 2021

Long-term outcome for children with minimal-change nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.24

7 January 2021

Initial treatment of idiopathic nephrotic syndrome in children: prednisone versus prednisone plus cyclosporine A: a prospective, randomized trial

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.24

7 January 2021

Comparison of cyclosporin and chlorambucil in the treatment of steroid-dependent idiopathic nephrotic syndrome: a multicentre randomized controlled trial. The French Society of Paediatric Nephrology

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.24

7 January 2021

A meta-analysis of cytotoxic treatment for frequently relapsing nephrotic syndrome in children

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.24

7 January 2021

Cyclosporine microemulsion increases drug exposure and reduces acute rejection without incremental toxicity in de novo renal transplantation. International Sandimmun Neoral Study Group

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.24

7 January 2021

Comparison of microemulsion and conventional formulations of cyclosporine A in preventing acute rejection in de novo kidney transplant patients. The U.K. Neoral Renal Study Group

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.24

7 January 2021

Clinical validation studies of Neoral C(2) monitoring: a review

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.24

7 January 2021

Patient management by Neoral C(2) monitoring: an international consensus statement

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.24

7 January 2021